Back
Minerva Neurosciences Vs. Karyopharm Therapeutics Industry Stock Comparison
Sell
45
NERV
Minerva Neurosciences
Last Price:
2.50
Seasonality Move:
22.08%
Buy
51
KPTI
Karyopharm Therapeutics
Last Price:
1.03
Seasonality Move:
-3.19%
Sell
45
Minerva Neurosciences (NERV)
is a Sell
Is Minerva Neurosciences a Buy, Sell or Hold?
- The current Minerva Neurosciences [NERV] share price is $2.50. The Score for NERV is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NERV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Karyopharm Therapeutics (KPTI)
is a Buy
Is Karyopharm Therapeutics a Buy, Sell or Hold?
- The current Karyopharm Therapeutics [KPTI] share price is $1.10. The Score for KPTI is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- KPTI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NERV Stock Price Chart
What is Minerva Neurosciences's stock price today?
-
The Minerva Neurosciences share price today is $2.50
The current trend is relatively stagnant and NERV is experiencing slight buying pressure.
KPTI Stock Price Chart
What is Karyopharm Therapeutics's stock price today?
-
The Karyopharm Therapeutics share price today is $1.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing selling pressure, which indicates risk of future bearish movement.
NERV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 43.22 | Sell |
| Chaikin Money Flow: | 7971 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.4 - 2.54) | Buy |
| Bollinger Bands (100): | (2.36 - 8) | Sell |
KPTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 44.14 | Sell |
| Chaikin Money Flow: | -806458 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.08 - 1.3) | Sell |
| Bollinger Bands (100): | (0.88 - 1.4) | Sell |
NERV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.4 | Buy |
| 20-day SMA: | 2.45 | Buy |
| 50-day SMA: | 2.57 | Sell |
| 200-day SMA: | 6.09 | Sell |
| 8-day EMA: | 2.41 | Buy |
| 20-day EMA: | 2.49 | Buy |
| 50-day EMA: | 3.25 | Sell |
| 200-day EMA: | 5.18 | Sell |
KPTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.09 | Buy |
| 20-day SMA: | 1.15 | Sell |
| 50-day SMA: | 1.29 | Sell |
| 200-day SMA: | 1.16 | Sell |
| 8-day EMA: | 1.11 | Sell |
| 20-day EMA: | 1.16 | Sell |
| 50-day EMA: | 1.21 | Sell |
| 200-day EMA: | 1.46 | Sell |
Minerva Neurosciences Earnings Growth & NERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.17 per share, an increase this year of $2.49 per share, and a decrease next year of $1.83 per share.
Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.08 per share, an increase this year of $0.02 per share, and an increase next year of $0.17 per share.
Minerva Neurosciences Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Karyopharm Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||